4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-23-047103
Chief Development Officer sold 1,490 shares at $16.66 ($24,817)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curley Joanne Chief Development Officer | 2023-08-21 | Sale 10b5-1 | −1,490 | $16.66 | $24,817 | 26,962 | D |
| Open-market sales · 1,490 sh · avg $16.66 · $24,817 | |||||||
Loading xslF345X05/doc4.xml…